Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

astrazeneca-sign

AstraZeneca’s Calquence shows strength in most common adult leukaemia

June 6, 2019
Research and Development AstraZeneca, Calquence, chronic lymphocytic leukaemia, pharma

AstraZeneca has unveiled new Phase 3 data for Calquence (acalabrutinib) in treatment-naïve chronic lymphocytic leukaemia, showing that the drug met …

News
donald_trump-_image_credit_gage_skidmore

Donald Trump causes confusion as to whether NHS will be ‘on the table’ in trade deal talks

June 6, 2019
Business Services, Medical Communications Donald Trump, NHS, UK, US, healthcare, pharma

President Donald Trump has caused confusion as to whether or not the NHS will ‘be on the table’ in post-Brexit …

News
merckincweb2

FDA approves new indication for MSD’s Zerbaxa

June 5, 2019
Research and Development Merck, Zerbaxa, bacterial infection, pharma

The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial …

News
abbvie_0

AbbVie’s Venclyxto combo outclasses chemo in treatment-naive chronic lymphocytic leukaemia

June 5, 2019
Research and Development ASCO 2019, AbbVie, Venclyxto, pharma

AbbVie was one of many companies to present new data at this year’s American Society of Clinical Oncology (ASCO) Annual …

News
lilly_entrance_web

Eli Lilly’s Emgality approved in the US for episodic cluster headache

June 5, 2019
Research and Development, Sales and Marketing Eli Lilly, Emgality, episodic cluster headache, migraine, pharma

Eli Lilly’s Emgality (galcanezumab-gnlm) self-administered injection solution has secured approval in the US for the treatment of episodic cluster headache, …

News
scott_gottlieb

Former FDA Commissioner returns to venture capital firm

June 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma

Dr Scott Gottlieb, former Commissioner for the FDA, has returned to his venture capital background with the announcement that he …

Appointment
shutterstock_159488225

Darzalex combo makes strong Phase 3 showing in multiple myeloma

June 4, 2019
Manufacturing and Production, Research and Development ASCO 2019, Cancer, Janssen, darzalex, multiple myeloma, pharma

Janssen joined its contemporaries at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago in the release …

News
janssen_latest_logo_on_sign

Janssen’s Imbruvica shows superiority in Phase 3 trials

June 4, 2019
Manufacturing and Production Janssen, imbruvia, leukaemia, pharma, phase 3, trial

Phase 3 data from ASCO 2019 has shown Janssen’s leukaemia drug Imbruvica (ibrutinib) had significant benefits over ofatumumab. In the …

News

EMA approves Bluebird Bio’s gene therapy Zynteglo

June 4, 2019
Manufacturing and Production Bluebird Bio, European comission, gene therapy, health, pharma

The European Commission has granted a conditional marketing authorisation to bluebird bio’s gene therapy Zynteglo. The Massachusetts-based firm’s one time …

News

Walmart join MediLedger medical supply chain blockchain network

June 3, 2019
Manufacturing and Production MediLedger, blockchain, medical supply chain, pharma

Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the …

News

Working Life: Monika Pocinkova, Vice President, HR Speciality Care, Ipsen UK & Ireland

June 3, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, pharma

Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …

Feature

Isatuximab improves on standard of care treatments for multiple myeloma

June 3, 2019
Sales and Marketing Cancer, Immunogen, Sanofi, isatuximab, multiple myeloma, pharma

Sanofi and ImmunoGen’s isatuximab combination therapy prolonged progression free survival by five months compared to standard of care treatments in …

News

Novartis’ Kisqali combo boosts survival in HR+/HER2- advanced breast cancer

June 3, 2019
Research and Development, Sales and Marketing Cancer, Kisqali, Novartis, breast cancer, pharma

Novartis took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to reveal new Phase 3 …

News
dietmar_berger

Dr Dietmar Berger returns to big pharma

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atara, R&D, Sanofi, oncology, pharma, research

Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …

Appointment
biogen_austria_238

Biogen’s diroximel fumarate impresses at Phase 3 in relapsing multiple sclerosis

May 31, 2019
Medical Communications, Research and Development Biogen, diroximel fumarate, multiple sclerosis, pharma, relapsingg multiple sclerosis

New data for Biogen’s investigational therapy diroximel fumarate has been revealed at the Consortium of Multiple Sclerosis Centers (CMSC) in …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026